BioNxt Solutions Inc.: BioNxt Solutions Unveils Accelerated 90-Day Plan: Global Patent Advancements, MS Clinical Trial, and Anti-Aging Expansion
VANCOUVER, BC / ACCESS Newswire / February 19, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC ...
Hear full audio of JPMorgan employee's work-from-home challenge that triggered CEO Jamie Dimon's foul-mouthed meltdown
JPMorgan workers were heard nervously laughing as colleague Nicolas Welch asked his question, prompting a now-notorious rant ...
Opus Genetics, Inc.: Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...